Laboratory Corporation of America Holdings (LH)

289.30
+5.57(+1.96%)
After Hours
289.30
-0.37(-0.13%)
- Real-time Data
  • Volume:
    622,079
  • Bid/Ask:
    277.70/299.68
  • Day's Range:
    284.00 - 296.00

LH Overview

Prev. Close
283.73
Day's Range
284-296
Revenue
16.55B
Open
286.34
52 wk Range
195.88-309.6
EPS
28.17
Volume
622,079
Market Cap
27.69B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
572,145
P/E Ratio
10.27
Beta
1.01
1-Year Change
44.65%
Shares Outstanding
95,700,000
Next Earnings Date
Feb 17, 2022
What is your sentiment on Laboratory Corporation of America Holdings?
or
Market is currently closed. Voting is open during market hours.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company has a collaboration agreement with community clinical oncology research network, LLC to understand the impact of disparities in precision medicine for people with cancer; and strategic collaboration with GeneCentric Therapeutics, Inc. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyBuy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryStrong SellSellStrong BuyStrong BuyStrong Buy
  • Where is the talk on LH?
    0
    • Last call!
      0
      • No raises, no matching retirement, reducing workforce...might not be good for employees, but the stock is rising...glad I'm retired, cause they don't care about the workers. But I've made about 10G the last 4 months.
        0
        • one of the good stocks that can give profit.  I am holding with profit. Hope it will reach above 220
          0
          • Before end of July your hope will come true.
            0
          • me too.
            0
        • I am so impressed with the performance of this stock... making money... it so much fun
          3
          • Great Job! time to buy it ...
            1
            • They may profit from all this...
              0
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.